Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

News Briefs:

News Briefs: At the annual meeting of the Society for Neuroscience in Washington, last November, Alzheimer's disease researchers presented findings that a breakthrough in the search for a cure. Peter Davies and could signal of Albert Einstein Medical College of New York have Benjamin Wolozin identified an abnormal protein in the brains of Alzheimer's victims that in the spinal fluid of living patients believed to have the also appears Because it has not been linked to other brain disorders and ap- disease. to be to Alzheimer's disease, the protein, called A-68, may pears unique accurate indicator of AD in living people. be the first fully diagnostic a test for the If A-68 holds up as a reliable indicator, routine diagnostic disease would not be far off. An experimental drug for Alzheimer's disease shows promise in tem- a study in theNew relieving symptoms in some patients, reports porarily EnglandJournal ofMedicine (November Of the 17 patients given the 13). in memory. The drug, called drug, 16 showed significant improvement or is only available to physicians using it tetrahydroaminoacridine, THA, studies. THA apparently works experimentally in carefully controlled that limits the production of blocking the action of an enzyme by nerve cells in a http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Alzheimer's Care and Related Disorders SAGE

News Briefs:

Download PDF
2 pages

Loading next page...
 
/lp/sage/news-briefs-T0uoCmls0i
Publisher
SAGE
Copyright
Copyright © 2019 by Sage Publications
ISSN
0888-4897
DOI
10.1177/153331758600100410
Publisher site
See Article on Publisher Site

Abstract

At the annual meeting of the Society for Neuroscience in Washington, last November, Alzheimer's disease researchers presented findings that a breakthrough in the search for a cure. Peter Davies and could signal of Albert Einstein Medical College of New York have Benjamin Wolozin identified an abnormal protein in the brains of Alzheimer's victims that in the spinal fluid of living patients believed to have the also appears Because it has not been linked to other brain disorders and ap- disease. to be to Alzheimer's disease, the protein, called A-68, may pears unique accurate indicator of AD in living people. be the first fully diagnostic a test for the If A-68 holds up as a reliable indicator, routine diagnostic disease would not be far off. An experimental drug for Alzheimer's disease shows promise in tem- a study in theNew relieving symptoms in some patients, reports porarily EnglandJournal ofMedicine (November Of the 17 patients given the 13). in memory. The drug, called drug, 16 showed significant improvement or is only available to physicians using it tetrahydroaminoacridine, THA, studies. THA apparently works experimentally in carefully controlled that limits the production of blocking the action of an enzyme by nerve cells in a

Journal

American Journal of Alzheimer's Care and Related Disorders – SAGE

Published: Sep 4, 2016

There are no references for this article.